Skip to main content

Table 1 ADC values of tumour entities and subgroups at baseline and during follow-up

From: Quantitative DWI predicts event-free survival in children with neuroblastic tumours: preliminary findings from a retrospective cohort study

  ADC baseline ADC follow-up
NB all n = 15 n = 11
0.76 ± 0.11 0.89 ± 0.29
(0.58–0.95) (0.49–1.49)
GNB + GN n = 4 n = 2
1.47 ± 0.23 GNB 0.90
(1.15–1.69) GN 1.84
NB with therapy n = 6 n = 5
0.70 ± 0.08 0.71 ± 0.25
(0.58–0.79) (0.49–1.14)
NB with observation n = 7 n = 4
0.82 ± 0.09 0.93 ± 0.12
(0.65–0.95) (0.77–1.06)
NB with risk factors n = 6 n = 5
0.70 ± 0.08 0.72 ± 0.25
(0.58–0.79) (0.78–1.50)
NB without risk factors n = 9 n = 7
0.79 ± 0.11 1.04 ± 0.23
(0.59–0.95) (0.77–1.50)
  1. ADC apparent diffusion coefficient, GN ganglioneuroma, GNB ganglioneuroblastoma, NB neuroblastoma
  2. Data is presented as mean ± standard deviation and range (minimum–maximum)